Philips has secured the US Food and Drug Administration (FDA) 510(k) approval for its SmartSpeed Precise dual AI software, enhancing AI-powered MRI technology.
The software, designed to optimise MRI scans, promises up to three times faster scanning and 80% sharper images, offering a seamless, one-click solution for healthcare providers.
Unveiled at ECR 2025, SmartSpeed Precise is now approved for clinical use across Philips’ entire range of 1.5T and 3.0T MRI systems, including its existing installations.
The development is set to enhance workflow efficiency and throughput without compromising image quality, making it a transformative tool for radiology teams.
Philips MR business leader Ioannis Panagiotelis said: “This FDA clearance is a powerful validation of Philips’ leadership in AI-powered MRI innovation.
“SmartSpeed Precise reflects our commitment to continuous innovation that addresses clinicians’ real-world pressures.
“By integrating dual AI with our proven Compressed SENSE engine, we are enabling faster, sharper, and smarter MR scans, making high-quality imaging more accessible and efficient than ever before.”
SmartSpeed Precise integrates three advanced technologies: Compressed SENSE, an AI-powered denoising engine, and a second AI engine for image sharpening and anti-ringing.
The dual AI approach enables high-quality exams at superior speeds, with a user-friendly single-click workflow adaptable to various denoising preferences.
Additionally, the software addresses critical challenges in radiology departments by reducing scan times and increasing throughput, thereby alleviating patient backlogs.
It delivers sharper images, enhancing diagnostic confidence in complex fields such as neurology, oncology, and cardiology.
The streamlined workflow ensures consistent imaging across diverse patient anatomies, even in challenging cases.
Philips is offering the SmartSpeed Precise software for both new MRI installations and existing 1.5T and 3.0T systems.
It serves as a scalable, cost-effective upgrade that enhances clinical performance without needing new hardware.
University Hospital Bonn radiology professor Julian Luetkens said: “SmartSpeed Precise helps us do what was previously thought impossible, deliver sharper, faster MRI with less effort.
“In breast MRI, we saw acquisition times reduced by up to 50%, with image quality improving compared to previous Compressed SENSE protocols. That’s a game-changer.”
Earlier this year, Philips entered a collaboration with NVIDIA to advance magnetic resonance (MR) imaging using artificial intelligence (AI).
The partnership aims to leverage AI to improve scan times, workflow efficiency, and image quality, enabling healthcare providers to deliver faster and more accurate diagnoses.
